The molecular diagnostics industry is experiencing tremendous growth, and it’s an excellent time to expand your market share. However, navigating this industry’s complex and challenging aspects can be difficult. According to a Laboratory Economics survey, 38% of respondents cited prior authorization test order requirements as their top concern in October 2020. As more tests move to the home and with ongoing diagnostic coding changes and regulatory variations, molecular diagnostics leaders have much to factor into their business and go-to-market strategies.

Read our in-depth white paper to learn practical approaches, process enhancements, and payor strategies essential to growing novel diagnostic market share through proactive, purposeful, and technologically enabled engagements with patients, physicians, and payors.

You’ll discover a path to increasing market share by learning how to:

• Increase physician engagement and revenue with molecular diagnostic strategies
• Maximize clean claims, automate denials, and execute payor-specific appeals strategies to maximize reimbursement
• Increase cash collections and work in tandem with EHRs to facilitate physician adoption and efficient ordering of novel and esoteric testing using a purpose-built revenue cycle management solution
• Use effective patient communication touchpoints and technology enablers to support patients in preparing for out-of-pocket expenses and increase test completion rates
• Use automation and process enhancement opportunities for prior authorizations, insurance discovery, benefits determination, eligibility verification, front-end payor edits, exception processing, and denials and appeals management
• Increase patient test completion rates
• Make informed decisions with molecular diagnostic business intelligence and analytics
• Use efficiency improvements for molecular diagnostic prior authorizations, insurance discovery, and more

Download the white paper now to learn how maximizing automation and streamlining workflows help increase revenue, patient access, and physician engagement.